Induction of Efflux-Mediated Macrolide Resistance in Streptococcus pneumoniae

ABSTRACT The antimicrobial efflux system encoded by the operon mef(E)-mel on the mobile genetic element MEGA in Streptococcus pneumoniae and other Gram-positive bacteria is inducible by macrolide antibiotics and antimicrobial peptides. Induction may affect the clinical response to the use of macrolides. We developed mef(E) reporter constructs and a disk diffusion induction and resistance assay to determine the kinetics and basis of mef(E)-mel induction. Induction occurred rapidly, with a >15-fold increase in transcription within 1 h of exposure to subinhibitory concentrations of erythromycin. A spectrum of environmental conditions, including competence and nonmacrolide antibiotics with distinct cellular targets, did not induce mef(E). Using 16 different structurally defined macrolides, induction was correlated with the amino sugar attached to C-5 of the macrolide lactone ring, not with the size (e.g., 14-, 15- or 16-member) of the ring or with the presence of the neutral sugar cladinose at C-3. Macrolides with a monosaccharide attached to C-5, known to block exit of the nascent peptide from the ribosome after the incorporation of up to eight amino acids, induced mef(E) expression. Macrolides with a C-5 disaccharide, which extends the macrolide into the ribosomal exit tunnel, disrupting peptidyl transferase activity, did not induce it. The induction of mef(E) did not require macrolide efflux, but the affinity of macrolides for the ribosome determined the availability for efflux and pneumococcal susceptibility. The induction of mef(E)-mel expression by inducing macrolides appears to be based on specific interactions of the macrolide C-5 saccharide with the ribosome that alleviate transcriptional attenuation of mef(E)-mel.

[1]  W. Shafer,et al.  Human Antimicrobial Peptide LL-37 Induces MefE/Mel-Mediated Macrolide Resistance in Streptococcus pneumoniae , 2010, Antimicrobial Agents and Chemotherapy.

[2]  D. Farrell,et al.  Increase in Pneumococcus Macrolide Resistance, United States , 2009, Emerging infectious diseases.

[3]  A. Mankin,et al.  Induction of erm(C) Expression by Noninducing Antibiotics , 2008, Antimicrobial Agents and Chemotherapy.

[4]  P. Wayne PERFORMANCE STANDARDS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING, NINTH INFORMATIONAL SUPPLEMENT , 2008 .

[5]  R. Koncan,et al.  Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae. , 2007, The Journal of antimicrobial chemotherapy.

[6]  R. Hakenbeck,et al.  A new integrative reporter plasmid for Streptococcus pneumoniae. , 2007, FEMS microbiology letters.

[7]  A. Bogdanov,et al.  Peptide derivatives of tylosin-related macrolides , 2007, Russian Journal of Bioorganic Chemistry.

[8]  A. Kwon,et al.  ermK leader peptide: Amino acid sequence critical for induction by erythromycin , 2006, Archives of pharmacal research.

[9]  J. Claverys,et al.  Antibiotic Stress Induces Genetic Transformability in the Human Pathogen Streptococcus pneumoniae , 2006, Science.

[10]  M. Mulvey,et al.  Expression of the mef(E) Gene Encoding the Macrolide Efflux Pump Protein Increases in Streptococcus pneumoniae with Increasing Resistance to Macrolides , 2005, Antimicrobial Agents and Chemotherapy.

[11]  D. Stephens,et al.  Macrolide Efflux in Streptococcus pneumoniae Is Mediated by a Dual Efflux Pump (mel and mef) and Is Erythromycin Inducible , 2005, Antimicrobial Agents and Chemotherapy.

[12]  Steven D. Brown,et al.  Emergence and Spread of Streptococcus pneumoniae with erm(B) and mef(A) Resistance , 2005, Emerging infectious diseases.

[13]  K. Klugman,et al.  Hidden Epidemic of Macrolide-resistant Pneumococci , 2005, Emerging infectious diseases.

[14]  A. Schuchat,et al.  Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment , 2005, The Lancet.

[15]  J. Poehlsgaard,et al.  The structural basis of macrolide-ribosome binding assessed using mutagenesis of 23S rRNA positions 2058 and 2059. , 2004, Journal of molecular biology.

[16]  S. Doktor,et al.  Characterization and Prevalence of MefA, MefE, and the Associated msr(D) Gene in Streptococcus pneumoniae Clinical Isolates , 2004, Journal of Clinical Microbiology.

[17]  D. Bejuk [Differentiation of resistance phenotypes among erythromycin-resistant streptococci]. , 2004, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti.

[18]  G. Syrogiannopoulos,et al.  Antimicrobial Susceptibility and Macrolide Resistance Inducibility of Streptococcus pneumoniae Carrying erm(A), erm(B), or mef(A) , 2003, Antimicrobial Agents and Chemotherapy.

[19]  R. Berisio,et al.  Structural Insight into the Antibiotic Action of Telithromycin against Resistant Mutants , 2003, Journal of bacteriology.

[20]  Frank Schluenzen,et al.  Structural insight into the role of the ribosomal tunnel in cellular regulation , 2003, Nature Structural Biology.

[21]  S. Connell,et al.  Erythromycin, roxithromycin, and clarithromycin: use of slow-binding kinetics to compare their in vitro interaction with a bacterial ribosomal complex active in peptide bond formation. , 2003, Molecular pharmacology.

[22]  Poul Nissen,et al.  The structures of four macrolide antibiotics bound to the large ribosomal subunit. , 2002, Molecular cell.

[23]  K. Klugman,et al.  Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections , 2002, European Respiratory Journal.

[24]  P. Braga Rokitamycin: Bacterial Resistance to a 16-Membered Ring Macrolide Differs from that to 14- and 15-Membered Ring Macrolides , 2002, Journal of chemotherapy.

[25]  F. Schluenzen,et al.  Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria , 2001, Nature.

[26]  D. Stephens,et al.  Structure and dissemination of a chromosomal insertion element encoding macrolide efflux in Streptococcus pneumoniae. , 2001, The Journal of infectious diseases.

[27]  M. Ferraro Performance standards for antimicrobial susceptibility testing , 2001 .

[28]  B. Vester,et al.  Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin. , 2000, Journal of molecular biology.

[29]  M. P. Montanari,et al.  In vitro activity of ketolides telithromycin and HMR 3004 against italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility. , 2000, The Journal of antimicrobial chemotherapy.

[30]  J. Claverys,et al.  Cross‐regulation of competence pheromone production and export in the early control of transformation in Streptococcus pneumoniae , 2000, Molecular microbiology.

[31]  A. Schuchat,et al.  The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment. , 2000, The Journal of infectious diseases.

[32]  J. Karlowsky,et al.  Ribosomal resistance: Emerging problems and potential solutions , 1999, Current infectious disease reports.

[33]  Ryochi Fujii,et al.  Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics. , 1999, The Journal of antimicrobial chemotherapy.

[34]  J. Claverys,et al.  Development of competence in Streptococcus pneumoniae: pheromone autoinduction and control of quorum sensing by the oligopeptide permease , 1998, Molecular microbiology.

[35]  W. Yuan,et al.  mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae , 1997, Antimicrobial agents and chemotherapy.

[36]  A. Girard,et al.  Ketolides lack inducibility properties of MLS(B) resistance phenotype. , 1997, The Journal of antimicrobial chemotherapy.

[37]  B. Weisblum,et al.  Induction of ermSV by 16-membered-ring macrolide antibiotics , 1997, Antimicrobial agents and chemotherapy.

[38]  A. Kamath,et al.  Molecular cloning and functional analysis of a novel macrolide‐resistance determinant, mefA, from Streptococcus pyogenes , 1996, Molecular microbiology.

[39]  T. Grebe,et al.  Detection of erythromycin-resistant determinants by PCR , 1996, Antimicrobial agents and chemotherapy.

[40]  J. Claverys,et al.  Competence pheromone, oligopeptide permease, and induction of competence in Streptococcus pneumoniae , 1996, Molecular microbiology.

[41]  J. Sutcliffe,et al.  Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system , 1996, Antimicrobial agents and chemotherapy.

[42]  D. Morrison,et al.  An unmodified heptadecapeptide pheromone induces competence for genetic transformation in Streptococcus pneumoniae. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[43]  B. Weisblum,et al.  Insights into erythromycin action from studies of its activity as inducer of resistance , 1995, Antimicrobial agents and chemotherapy.

[44]  B. Weisblum,et al.  Transcriptional attenuation control of ermK, a macrolide-lincosamide-streptogramin B resistance determinant from Bacillus licheniformis , 1991, Journal of bacteriology.

[45]  D. Morrison,et al.  Genetic transformation in Streptococcus pneumoniae: nucleotide sequence analysis shows comA, a gene required for competence induction, to be a member of the bacterial ATP-dependent transport protein family , 1991, Journal of bacteriology.

[46]  J. Wootton,et al.  Inducible erythromycin resistance in staphlyococci is encoded by a member of the ATP‐binding transport super‐gene family , 1990, Molecular microbiology.

[47]  M. Mayford,et al.  The ermC leader peptide: amino acid alterations leading to differential efficiency of induction by macrolide-lincosamide-streptogramin B antibiotics , 1990, Journal of bacteriology.

[48]  B. Weisblum,et al.  Erythromycin-induced ribosome stall in the ermA leader: a barricade to 5'-to-3' nucleolytic cleavage of the ermA transcript , 1989, Journal of bacteriology.

[49]  M. Mayford,et al.  ermC leader peptide. Amino acid sequence critical for induction by translational attenuation. , 1989, Journal of molecular biology.

[50]  B. Lampson,et al.  Novel mechanism for plasmid-mediated erythromycin resistance by pNE24 from Staphylococcus epidermidis , 1986, Antimicrobial Agents and Chemotherapy.

[51]  Jeffrey H. Miller Experiments in molecular genetics , 1972 .